Recommend to a friend
Applying the Evidence on Antifibrotic Agents for IPF
Drs. David J. Lederer and Fernando J. Martinez address the following topics:
- How should patients be managed who experience disease progression while on antifibrotic therapy?
- Is there enough evidence on mortality with antifibrotic therapy to discuss this with patients?
